CML clonal evolution with resistance to single agent imatinib therapy

Ronan T Swords, J. Quinn, M. Fay, R. O'Donnell, J. Goldman, P. T. Murphy

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

We describe a 58-year-old male diagnosed with chronic myeloid leukaemia (CML) who failed to have a cytogenetic response to interferon-α and hydroxyurea. On subsequent therapy with imatinib mesylate he failed to have any cytogenetic response but also developed a complex clonal evolution with an additional Philadelphia (Ph) chromosome and trisomy 8 respectively in two Ph-positive subclones. The addition of cytosine arabinoside to imatinib resulted in reversion to single Ph-chromosome positivity with the disappearance of the previous additional clonal abnormalities. The case demonstrates the efficacy of combined treatment with imatinib and cytarabine in the management of CML resistant to single agent imatinib.

Original languageEnglish
Pages (from-to)347-349
Number of pages3
JournalClinical and Laboratory Haematology
Volume27
Issue number5
DOIs
StatePublished - Oct 1 2005
Externally publishedYes

Fingerprint

Clonal Evolution
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Philadelphia Chromosome
Cytarabine
Chromosomes
Cytogenetics
Chromosomes, Human, Pair 8
Hydroxyurea
Therapeutics
Interferons
Imatinib Mesylate

Keywords

  • Chronic myeloid leukaemia
  • Clonal evolution
  • Imatinib
  • Philadelphia chromosome
  • Resistance

ASJC Scopus subject areas

  • Hematology

Cite this

Swords, R. T., Quinn, J., Fay, M., O'Donnell, R., Goldman, J., & Murphy, P. T. (2005). CML clonal evolution with resistance to single agent imatinib therapy. Clinical and Laboratory Haematology, 27(5), 347-349. https://doi.org/10.1111/j.1365-2257.2005.00721.x

CML clonal evolution with resistance to single agent imatinib therapy. / Swords, Ronan T; Quinn, J.; Fay, M.; O'Donnell, R.; Goldman, J.; Murphy, P. T.

In: Clinical and Laboratory Haematology, Vol. 27, No. 5, 01.10.2005, p. 347-349.

Research output: Contribution to journalArticle

Swords, RT, Quinn, J, Fay, M, O'Donnell, R, Goldman, J & Murphy, PT 2005, 'CML clonal evolution with resistance to single agent imatinib therapy', Clinical and Laboratory Haematology, vol. 27, no. 5, pp. 347-349. https://doi.org/10.1111/j.1365-2257.2005.00721.x
Swords, Ronan T ; Quinn, J. ; Fay, M. ; O'Donnell, R. ; Goldman, J. ; Murphy, P. T. / CML clonal evolution with resistance to single agent imatinib therapy. In: Clinical and Laboratory Haematology. 2005 ; Vol. 27, No. 5. pp. 347-349.
@article{c78b15c4bea54162815a0c6fe63a91f3,
title = "CML clonal evolution with resistance to single agent imatinib therapy",
abstract = "We describe a 58-year-old male diagnosed with chronic myeloid leukaemia (CML) who failed to have a cytogenetic response to interferon-α and hydroxyurea. On subsequent therapy with imatinib mesylate he failed to have any cytogenetic response but also developed a complex clonal evolution with an additional Philadelphia (Ph) chromosome and trisomy 8 respectively in two Ph-positive subclones. The addition of cytosine arabinoside to imatinib resulted in reversion to single Ph-chromosome positivity with the disappearance of the previous additional clonal abnormalities. The case demonstrates the efficacy of combined treatment with imatinib and cytarabine in the management of CML resistant to single agent imatinib.",
keywords = "Chronic myeloid leukaemia, Clonal evolution, Imatinib, Philadelphia chromosome, Resistance",
author = "Swords, {Ronan T} and J. Quinn and M. Fay and R. O'Donnell and J. Goldman and Murphy, {P. T.}",
year = "2005",
month = "10",
day = "1",
doi = "10.1111/j.1365-2257.2005.00721.x",
language = "English",
volume = "27",
pages = "347--349",
journal = "International Journal of Laboratory Hematology",
issn = "1751-5521",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - CML clonal evolution with resistance to single agent imatinib therapy

AU - Swords, Ronan T

AU - Quinn, J.

AU - Fay, M.

AU - O'Donnell, R.

AU - Goldman, J.

AU - Murphy, P. T.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - We describe a 58-year-old male diagnosed with chronic myeloid leukaemia (CML) who failed to have a cytogenetic response to interferon-α and hydroxyurea. On subsequent therapy with imatinib mesylate he failed to have any cytogenetic response but also developed a complex clonal evolution with an additional Philadelphia (Ph) chromosome and trisomy 8 respectively in two Ph-positive subclones. The addition of cytosine arabinoside to imatinib resulted in reversion to single Ph-chromosome positivity with the disappearance of the previous additional clonal abnormalities. The case demonstrates the efficacy of combined treatment with imatinib and cytarabine in the management of CML resistant to single agent imatinib.

AB - We describe a 58-year-old male diagnosed with chronic myeloid leukaemia (CML) who failed to have a cytogenetic response to interferon-α and hydroxyurea. On subsequent therapy with imatinib mesylate he failed to have any cytogenetic response but also developed a complex clonal evolution with an additional Philadelphia (Ph) chromosome and trisomy 8 respectively in two Ph-positive subclones. The addition of cytosine arabinoside to imatinib resulted in reversion to single Ph-chromosome positivity with the disappearance of the previous additional clonal abnormalities. The case demonstrates the efficacy of combined treatment with imatinib and cytarabine in the management of CML resistant to single agent imatinib.

KW - Chronic myeloid leukaemia

KW - Clonal evolution

KW - Imatinib

KW - Philadelphia chromosome

KW - Resistance

UR - http://www.scopus.com/inward/record.url?scp=26044474546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26044474546&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2257.2005.00721.x

DO - 10.1111/j.1365-2257.2005.00721.x

M3 - Article

C2 - 16178920

AN - SCOPUS:26044474546

VL - 27

SP - 347

EP - 349

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

SN - 1751-5521

IS - 5

ER -